Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Impalaman on May 01, 2021 8:06am

just out---

Dr.---mandel arkady---just bought 60.000 shares@--0.23----the doc's are starting  to buy in----that can't be a bad thing.
Comment by Rumpl3StiltSkin on May 01, 2021 10:08am
The Good Dr. probably 'knows' he just bought a 10x bagger. At least! ;-)
Comment by Pandora on May 01, 2021 12:08pm
As of 11:59pm ET May 1st, 2021 Filing Date Transaction Date Insider Name Ownership Type Securities Nature of transaction Volume or Value Price Apr 30/21 Apr 30/21 Mandel, Arkady Direct Ownership Common Shares 10 - Acquisition in the public market 60 ...more  
Comment by Bunge on May 01, 2021 10:30am
This is excellent. Been waiting to see people other than Roger buying. TLT is Roger's baby so of course he's super optimistic. To see Arkady buying though... This has punch. Keep buying Mandel!
Comment by CAinPlap on May 03, 2021 4:25pm
Nice to see insider buying but are some dumping knowing there will not be any news for awhile? 
Comment by floatinketucky on May 01, 2021 12:31pm
I wonder if the Dr. understands the rates? Watch out for the resident bashers! If your hands are not strong they will knock shares out of your hands with their tricky tricks and pick them up.   The doctor knows that we sit at 67% with three non pending patients.  The doctor knows that the nonresponder will get the second treatment.  The doctor knows that the other 3 data ...more  
Comment by CancerSlayer on May 01, 2021 1:25pm
Thanks Impalaman...made my weekend & that may be the best NR of the year!  The docs I know are generally a very measured & risk-averse bunch...the profession demands it.  Naturally, they can be very measured with their investments, if not frugal; I know a few.  Seeing almost $14K dropped on TLT....there couldn't be a better approving nod about our potential.  
Comment by Rumpl3StiltSkin on May 01, 2021 1:53pm
Yeah Slayer, I'm thinking these research Docs, in particular, see soo many 'great' ideas-technologies that never make it to commercialization. Dr. M sees this tech making it now. So he probably knows what we are just suspecting. Speculating $$ on for years now. :-) GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250